{
    "clinical_study": {
        "@rank": "167974", 
        "arm_group": [
            {
                "arm_group_label": "Arabinoxylanoligosaccharides (AXOS)", 
                "arm_group_type": "Active Comparator", 
                "description": "AXOS (2 x 5g WBE/day)"
            }, 
            {
                "arm_group_label": "Maltodextrine (placebo)", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Maltodextrine (2 x 5g/day)"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate the effect of AXOS on parameters of colon\n      metabolism and gut health"
        }, 
        "brief_title": "Effect of AXOS on the Colon Metabolism in Healthy Volunteers", 
        "completion_date": {
            "#text": "September 2012", 
            "@type": "Anticipated"
        }, 
        "condition": "Gut Health", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  healthy volunteers\n\n          -  regular dietary pattern (3 meals/day)\n\n          -  age: 18-45y\n\n          -  BMI: 18,5-27 kg/m2\n\n        Exclusion Criteria:\n\n          -  intake of antibiotics 1 month prior to the study\n\n          -  abdominal surgery in the past, with the exception of appendectomy\n\n          -  intake of medication influencing the gastro-intestinal system 14 days prior to the\n             study\n\n          -  in treatment at a dietician\n\n          -  serious liver- or kidney failure\n\n          -  vegetarians\n\n          -  intake of pre- and/or probiotics\n\n          -  Exposure to radioactivity 1 year prior to the study"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "45 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "July 30, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01656499", 
            "org_study_id": "ML7245"
        }, 
        "intervention": [
            {
                "arm_group_label": "Arabinoxylanoligosaccharides (AXOS)", 
                "intervention_name": "Arabinoxylanoligosaccharides", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "Maltodextrine (placebo)", 
                "intervention_name": "Maltodextrine", 
                "intervention_type": "Dietary Supplement"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "August 1, 2012", 
        "location": {
            "facility": {
                "address": {
                    "city": "Leuven", 
                    "country": "Belgium", 
                    "state": "Vlaams-Brabant", 
                    "zip": "3000"
                }, 
                "name": "UZ Leuven/KU Leuven"
            }
        }, 
        "location_countries": {
            "country": "Belgium"
        }, 
        "number_of_arms": "2", 
        "official_title": "Effect of AXOS on the Colon Metabolism in Healthy Volunteers", 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": [
                "Belgium: Ethics Committee", 
                "Belgium: Federal Agency for Medicinal Products and Health Products"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "July 2011", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Fecal water toxicity", 
            "safety_issue": "No", 
            "time_frame": "Participants are followed for 10 weeks, with measurements on 4 specific time points"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01656499"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Katholieke Universiteit Leuven", 
            "investigator_full_name": "Kristin Verbeke", 
            "investigator_title": "Professor Kristin Verbeke, Ph. D.", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Katholieke Universiteit Leuven", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Katholieke Universiteit Leuven", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2011", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "August 2012"
    }
}